Matt Orr
About Matt Orr
Matt Orr is the VP of Regulatory Affairs with a strong background in organic chemistry and extensive experience in the pharmaceutical industry.
Matt Orr - VP, Regulatory Affairs
Matt Orr currently serves as the Vice President of Regulatory Affairs. In this role, he oversees the regulatory strategy and compliance initiatives. His duties include monitoring regulatory changes, managing submissions and approvals, and liaising with regulatory authorities to ensure adherence to industry standards.
Matt Orr's Educational Background
Matt Orr holds a Doctor of Philosophy degree in Organic Chemistry from Duke University. He also earned a Bachelor of Science degree in Chemistry/Molecular & Cell Biology from Pennsylvania State University. His rigorous academic training provided a solid foundation in chemistry and molecular biology, contributing to his extensive knowledge and expertise in the field.
Matt Orr's Industry Expertise and Experience
Matt Orr has a diverse background in the chemical and pharmaceutical industries. He began his career as a Research Scientist at Scynexis, Inc., where he worked on developing new anti-infective and antineoplastic drug candidates. He then moved to BASF Corporation, serving as the Global Product Registration Manager, where he managed product registrations globally. His experience spans across scientific advising, technical writing, and consulting through his work at Discovery Innovations, a company he co-founded and where he served as Principal Scientist.
Matt Orr's Role at Discovery Innovations
Matt Orr co-founded Discovery Innovations and served as its Principal Scientist. In this role, he provided scientific advising and consulting services, as well as technical writing. The company focused on delivering innovative solutions and expertise in the scientific community, leveraging Matt's deep knowledge and experience in organic chemistry and molecular biology.
Research and Development Contributions by Matt Orr
Starting his professional career at Scynexis, Inc., Matt Orr contributed to developing novel anti-infective and antineoplastic drug candidates. His work in research and development focused on identifying and synthesizing new compounds with potential therapeutic applications, demonstrating his capability in advancing pharmaceutical science.